SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novavax NVAX
NVAX 7.910-5.8%9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: recycled_electron who wrote (115)10/21/2021 7:06:58 PM
From: Paul Senior1 Recommendation

Recommended By
recycled_electron

  Read Replies (1) of 166
 
I am going to believe the company, if it has manufacturing problems and approval delays because of that, that NVAX will overcome those issues. I believe that may be the only issue holding back approval. Lot of talk about how the ceo has promised approvals - Europe, USA, etc. (as early as last May), and how nothing has happened so far. Aside from questions about the competency of the ceo, there are questions as to whether the approval forms have even been submitted yet to the relevant authorities.

I believe NVAX will get approvals, and the stock should rise quickly and substantially at that news. Maybe further too when they soon after approval begin shipping.

Meanwhile, this stock has been very difficult for me to live with. It is one heck of a volatile stock. I've got a large position to which I have been continuing to add, and I am very in the red at this time.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News